1. Kratz M. Dietary Cholesterol, Atherosclerosis and Coronary Heart Disease. Atherosclerosis: Diet and Drugs Handbook of Experimental Pharmacology. 2005:195-213. doi:10.1007/3-540-27661-0_6.
2. Ivanova EA, Myasoedova VA, Melnichenko AA, Grechko AV, Orekhov AN. Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases. Oxidative Medicine and Cellular Longevity. 2017;2017:1-10. doi:10.1155/2017/1273042.
3. Prenner SB, Mulvey CK, Ferguson JF, Rickels MR, Bhatt AB, Reilly MP. Very low density lipoprotein cholesterol associates with coronary artery calcification in type 2 diabetes beyond circulating levels of triglycerides. Atherosclerosis. 2014;236(2):244-250. doi:10.1016/j.atherosclerosis.2014.07.008.
4. Kosmas CE, Martinez I, Sourlas A, et al. High-density lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease. Drugs in Context. 2018;7:1-9. doi:10.7573/dic.212525.
5. Mann S, Beedie C, Jimenez A. Differential Effects of Aerobic Exercise, Resistance Training and Combined Exercise Modalities on Cholesterol and the Lipid Profile: Review, Synthesis and Recommendations. Sports Medicine. 2013;44(2):211-221. doi:10.1007/s40279-013-0110-5.
6. Goh YK, Clandinin MT, Jumpsen JA, Ryan EA. Effect of omega 3 fatty acid on plasma lipids, cholesterol and lipoprotein fatty acid content in NIDDM patients. Diabetologia. 1997;40(1):45-52. doi:10.1007/s001250050641.
7. Bazzano LA. Effects of soluble dietary fiber on low-density lipoprotein cholesterol and coronary heart disease risk. Current Atherosclerosis Reports. 2008;10(6):473-477. doi:10.1007/s11883-008-0074-3.